CClinicalTrials.gg
CompletedNCT04473105Updated Apr 9, 2024

Optimising Resource Allocation Via Prediction of Outcomes for Covid-19

An observational study in COVID19, sponsored by Nottingham University Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Nottingham University Hospitals NHS Trust · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
11,134
Ages
18 Years and older
Sex
All
01

Study summary

The investigators plan to use all of the information available within their local NHS hospitals Trust to work out what happens to people admitted with both suspected and proven Covid-19 infections. The investigators will use all of the information that they can to provide the most evidence possible to use in their investigation as this will make the results more accurate. This will include information on existing health conditions (e.g. by looking at previous discharge letters, GP summaries), clinical observations recorded in the hospital (e.g. temperature, blood pressure, pulse, oxygen levels) and laboratory measures (e.g. blood markers of infection). The investigators experienced team will then analyse all of this together with information about whether the person has Covid-19 to help work out what any new patients' risk will be. To do this the investigators need to use individual patients' information, however once removed from the hospital records system it will not be identifiable and will be held securely within the hospital at all times. As a result of this work the investigators plan to be able to do two things:

  1. When a patient is admitted to hospital with possible or confirmed Covid-19 the investigators will be able to make a highly accurate prediction of what is likely to happen to them (e.g. being admitted to high dependency or intensive care, dying or surviving to discharge) which will help health care professional make decisions about their care.
  2. By knowing what is likely to happen to a patient the investigators are able to make informed decisions about how to distribute healthcare resources e.g. which areas are likely to need more ventilators (machines to help with breathing), need for intensive care beds, discharge planning.
Read the detailed description

Background.

Relatively simple clinical risk scores based upon easily available clinical information can greatly aid in the triaging of patients to early discharge or more rapid and intensive intervention. One example of this is in upper gastrointestinal bleeding where several such scores (https://www.mdcalc.com/glasgow-blatchford-bleeding-score-gbs4 5; https://www.mdcalc.com/rockall-score-upper-gi-bleeding-complete6) have permitted safe early discharge thereby relieving pressure on hospitals. The investigators believe that similar results might potentially be achievable from data routinely collected in our trust on patients with proven or suspected Covid-19.

Objectives

The investigators aim to answer the following questions

  1. What pattern of clinical history and symptoms, observations, blood and other investigative markers best predicts that a patient suspected of Covid-19 or proven to have it will progress to requiring ventilation?
  2. What pattern of clinical history and symptoms, observations, blood and other investigative markers best predicts that a patient suspected of Covid-19 or proven to have it will die during their illness?
  3. What pattern of clinical history and symptoms, observations, blood and other investigative markers best predicts that a patient suspected of Covid-19 or proven to have it will make a full recovery without requiring supplemental oxygen?

Methods

The investigators propose to two main approaches to the first two of the aims above.

A standard approach assessing baseline characteristics to predict poor outcome, similar to other ongoing studies like ISARIC and PRIEST, but benefitting from an unbiased sample of patients as no additional samples or data are to be collected and so the investigators believe that it will be ethically acceptable subject to due attention to confidentiality to analyse all patients presenting and not only those willing and able to consent.

A multi-level modelling approach that uses the rich repeated daily laboratory and clinical measurements to predict the daily risk of a subsequent deterioration.

This second approach complements other ongoing studies like ISARIC and PRIEST, as it can only feasibly be delivered within a single institution like NUH as it requires detailed longitudinal linked electronic health data. Furthermore, it is an efficient, low cost study design that does not require manual data collection.

The investigators will utilize the data held in the electronic systems of Nottingham University Hospitals (NUH) NHS Trust, to identify all patients either suspected of having Covid-19 infection or in whom the diagnosis is eventually confirmed. This will be performed from the start of the pandemic retrospectively and then in a rolling program prospectively to maximise available data.

For these patients the investigators will gather all relevant data on diagnoses (comorbidities), daily clinical observations and daily laboratory parameters both at presentation and on a rolling basis going forward from that until the point of death or discharge. These data will include repeated measures of, temperature, pulse, blood oxygen saturation, inspired oxygen concentration, respiratory rate, C reactive protein, and white cell count among others.

Data will be analysed, and outcomes modelled within the Nottingham University Hospitals Trust network to ensure that confidentiality is maintained.

Analysis

Characteristics of patients who go on to intubation The investigators will assess the association of any baseline parameters and demographics of patients who require ventilation compared to those who do not by cross tabulating baseline parameters with ventilation, and calculating adjusted associations using a logistic regression model. The investigators will also examine daily risk of intubation using a random effects model with the repeated daily measurements. In order to examine the potential for an easily calculable clinical risk score, logistic models will be prepared, but retaining continuous variables as continuous (to maximise the retention of useful predictive data) and reducing them to categorical data (for ease of clinical calculation). The investigators will select predictors for the model using backward elimination with the Akaike information criterion and alpha = 0.05. For candidate models the investigators will calculate the C-index and receiver operating curves and assess calibration using the Hosmer-Lemeshow test. Bootstrapping and cross validation will be used to avoid overfitting and assess model performance.

Time trends analysis to identify markers leading to intubation The investigators will examine the data for trends over time in repeated measurements where available and describe these using appropriate summary statistics. If there are enough repeated measurements, then each covariate will be assessed with a JoinPoint analysis to assess if there is an obvious inflexion in time to indicate a change in the clinical picture which marks a decline towards ventilation. This process will feed into the rational choice of categories for categorical representation of the data.

Predictors at intubation suggesting death The investigators will assess the association of any parameters and demographics of ventilated patients who die compared to those who do not by cross tabulating parameters at point of ventilation with death, and calculating adjusted associations using a logistic regression model. The investigators will also examine daily risk of death using a random effects model with the repeated daily measurements. In order to examine the potential for an easily calculable clinical risk score, logistic models will be prepared, but retaining continuous variables as continuous (to maximise the retention of useful predictive data) and reducing them to categorical data (for ease of clinical calculation). The investigators will select predictors for the model using backward elimination with the Akaike information criterion and alpha = 0.05. For candidate models the investigators will calculate the c index and receiver operating curves and assess calibration using the Hosmer-Lemeshow test. Bootstrapping and cross validation will be used to avoid overfitting and assess model performance.

Time trends analysis to identify markers leading to death We will examine the data for trends over time in repeated measurements where available and describe these using appropriate summary statistics. If there are enough repeated measurements, then each covariate will be assessed with a JoinPoint analysis to assess if there is an obvious inflexion in time to indicate a change in the clinical picture which marks a decline towards death Baseline characteristics of patients discharged without supplemental oxygen We will assess the association of any baseline parameters and demographics of patients who are discharged without supplemental oxygen compared to those who are not by cross tabulating baseline parameters with ventilation, and calculating adjusted associations using a logistic regression model. In order to examine the potential for an easily calculable clinical risk score, logistic models will be prepared, but retaining continuous variables as continuous (to maximise the retention of useful predictive data) and reducing them to categorical data (for ease of clinical calculation). The investigators will select predictors for the model using backward elimination with the Akaike information criterion and alpha = 0.05. For candidate models the investigators will calculate the c index and receiver operating curves and assess calibration using the Hosmer-Lemeshow test. Each of these steps will be repeated in 10 randomly selected 20% subsamples of the dataset.

Stratified supplemental analyses To identify different patient groups at risk of poor outcomes, interactions with each risk model will be assessed to identify if stratification is needed by age bands, sex, prior co-morbidities and baseline factors such as lymphopaenia, CRP etc.

All analyses will be repeated for groups of PCR proven Covid-19 patients and those only suspected.

For the analysis of discharge without supplemental oxygen the investigators will examine the risk of readmission for those so discharged and repeat the analysis only for those not subsequently readmitted.

Eligibility Criteria

Inclusion criteria • All patients admitted to Nottingham University Hospitals Trust either suspected of having Covid-19 infection or in whom the diagnosis is eventually confirmed and who are over the age of 18 years

Exclusion criteria

  • Aged under 18.
02

Conditions studied

  • COVID19

Browse trials for

Keywords

  • prognostic score
  • ventilation
  • mortality
  • early discharge
03

In context

COVID-19

7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 11,134 is above the median of 260 across 3,135 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Nottingham University Hospitals NHS Trust is the lead sponsor of 104 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients meeting above criteria during the study period and prior to it for whom follow up to 30 days can be completed during the period (i.e. admissions until 30 days prior to study closes)

Inclusion criteria

  • All patients admitted to Nottingham University Hospitals Trust either suspected of having Covid-19 infection or in whom the diagnosis is eventually confirmed and who are over the age of 18 years

Exclusion criteria

Exclusion Criteria:

  • Aged under 18.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
11,134 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Ventilation

    The need to ventilate the patient

    Time frame: During admission up to 3 months

Secondary outcomes

  1. Death

    Death of the patient

    Time frame: During admission or within 30 days

07

Study locations

1 site
  • Nottingham University Hospitals NHS Trust
    Nottingham, NG7 2UH, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04473105
Lead sponsor
Nottingham University Hospitals NHS Trust
Collaborators
East Midlands Academic Health Sciences Network
Responsible party
Sponsor
First posted
Jul 16, 2020
Start date
May 1, 2020
Primary completion
Dec 31, 2021
Completion
Mar 31, 2022
Last update
Apr 9, 2024

Study contacts

Timothy R Card, FRCP, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion